34 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and biological activity of 4-(diphenylmethyl)-alpha-[(4-quinolinyloxy)methyl]-1-piperazineethanol and related compounds.
Warner-Lambert
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships.
Warner-Lambert
Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity.
Suntory Institute For Biomedical Research
2-(2-Aryl-2-oxoethylidene)-1,2,3,4-tetrahydropyridines. Novel isomers of 1,4-dihydropyridine calcium channel blockers.
Warner-Lambert
Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
TBA
Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol.
Pharmacokinetics
Vascular L-type Ca²¿ channel blocking activity of sulfur-containing indole alkaloids from Glycosmis petelotii.
Vietnam Academy of Science and Technology
Selective optimization of side activities: another way for drug discovery.
Prestwick Chemical
Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
Fourth Military Medical University
De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailability.
Synaptic Pharmaceutical
Design and biological evaluation of non-peptide analogues of omega-conotoxin MVIIA.
Parke-Davis Neuroscience Research Centre
Synthesis and biological activity of substituted bis-(4-hydroxyphenyl)methanes as N-type calcium channel blockers.
Warner-Lambert
New purines and purine analogs as modulators of multidrug resistance.
Institut De Recherches Servier
Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric).
Seoul National University
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.
Solvay Duphar
Asymmetric synthesis and biological evaluations of (+)- and (-)-6-dimethoxymethyl-1,4-dihydropyridine-3-carboxylic acid derivatives blocking N-type calcium channels.
Ajinomoto Pharmaceuticals
Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker.
Universita Degli Studi Di Perugia
L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
Universita Degli Studi Di Bologna
Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening.
University of Perugia
The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Ajinomoto
Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action.
Universidad De Chile
Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Ajinomoto
Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.
Boehringer Ingelheim Pharma
Vasorelaxation by new hybrid compounds containing dihydropyridine and pinacidil-like moieties.
National Academy of Sciences of Ukraine
Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.
New York University Medical Center
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca.
Shandong University